Dyne Therapeutics (DYN) Times Interest Earned (2025)
Dyne Therapeutics (DYN) posted quarterly Times Interest Earned of -$2.05 for Q2 2026, up 19.29% quarter-over-quarter from -$2.54 in Q1 2026.
Analysis
Dyne Therapeutics (DYN) Times Interest Earned (2025) Analysis & Trends
Dyne Therapeutics (DYN) has reported Times Interest Earned for 8 consecutive years, with -$2.05 the latest figure, recorded in Q2 2026.
- In Q2 2026, Times Interest Earned changed N/A year-over-year to -$2.05; the TTM figure through Jun 2026 stood at -$6.05 (up 92.88% YoY), while the FY2025 annual figure was -$1.12, up 6.26% from the prior year.
- Times Interest Earned climbed to -$2.05 in Q2 2026 per DYN's latest filing, from -$2.54 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.35 in Q4 2022 and bottomed at -$45.61 in Q4 2025.
- Historically, Times Interest Earned has averaged -$8.97 across 5 years, with a median of -$2.28 in 2023.
- Annual changes were most pronounced in 2022 — Times Interest Earned soared 99.86% — and 2024, when it plunged 4098.65%.
- Dyne Therapeutics' Times Interest Earned stood at -$0.35 in 2022, then tumbled by 31.42% to -$0.46 in 2023, then slumped by 4098.65% to -$19.5 in 2024, then plunged by 133.96% to -$45.61 in 2025, then surged by 95.51% to -$2.05 in 2026.
- Business Quant data shows DYN's Times Interest Earned at -$2.05 in Q2 2026, -$2.54 in Q1 2026, and -$45.61 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Dyne Therapeutics | 4.02 Bn | 4.02 Bn | - | - |